Allied Market Research published a report, titled, “Nephrology and Urology Devices Market by Product (Instruments and Consumables & Accessories), by Application, (Kidney Diseases, Urological Cancer & BPH, and Others), and by End User, (Hospitals, Dialysis Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the global nephrology and urology devices industry generated USD 31.3 billion in 2022, and is anticipated to generate USD 47.8 billion by 2032, witnessing a CAGR of 4.3% from 2023 to 2032.
The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐๐ฉ๐ก๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ?
Increase in prevalence of kidney and urological disorders such as chronic kidney disease, urinary tract infections, kidney stones, & urologic cancers; surge in technological advancements; and rise in demand for minimally invasive medical procedures drive the growth of the global nephrology and urology devices market. However, the high cost of urology devices restricts market growth. Contrarily, growth prospects in emerging markets present new opportunities in the coming years.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/420 ย
๐๐๐จ๐ง๐จ๐ฆ๐ข๐ ๐๐จ๐ฐ๐ง๐ญ๐ฎ๐ซ๐ง ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ: ๐๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐๐๐๐ฌ๐ฌ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐จ๐ง ๐ญ๐ก๐ ๐๐๐ฉ๐ก๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
- During recession, individuals and governments might tighten their budgets, leading to reduced healthcare spending. This could affect patients’ ability to access & afford nephrology and urology devices, potentially leading to decreased demand for diagnostics. In addition, economic downturns lead to reduced funding for medical research and development. This could slow down the advancement of technologies and tools for nephrology and urology devices, potentially limiting the availability of more effective and less invasive diagnostic methods.
- However, rise in the prevalence of urological and nephrological diseases, increase in technological advancements, and growth in awareness about early diagnosis & treatment could boost the need for these devices, leading to a positive impact from the global recession.
๐๐จ๐ฉ ๐๐๐ฉ๐ก๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:-
- B. Braun SE
- Baxter International Inc.
- Becton, Dickson and Company
- Boston Scientific Corporation
- Coloplast Ltd
- Karl Storz GmbH & Co. KG
- Medtronic plc
- Olympus Corporation
- Stryker Corporation
- Teleflex Incorporated
The report provides a detailed analysis of these key players in the global nephrology and urology devices market. These players have adopted strategies such as product launch, product approval, acquisition, agreement, and partnership to increase their market share and maintain dominant position in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ฉ๐ก๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐๐ซ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:-
Based on product, the consumables and accessories segment held the largest market share in 2022, accounting for more than three-fifths of the global nephrology and urology devices market revenue and is estimated to maintain its leadership status throughout the forecast period. This segment is projected to manifest the highest CAGR of 4.5% from 2023 to 2032. This is attributed to rise in prevalence of chronic kidney diseases and growth in aging population, which led to surge in demand for urological devices such as consumables.
Depending on application, the kidney diseases segment held the largest market share in 2022, accounting for more than half of the global nephrology and urology devices market and is estimated to maintain its leadership status throughout the forecast period. Increase in the number of people suffering from chronic kidney diseases has led to increase in the demand for urology and nephrology devices which propels the segment growth.
However, the urological cancer & BPH segment is projected to manifest the highest CAGR of 5.4% from 2023 to 2032. This is attributed to increase in awareness of urological cancers, advances in medical technology, and rise in aging population, bring more susceptible to urological conditions such as cancer and BPH.
As per end user, the hospitals segment accounted for the largest share in 2022, contributing to nearly more than two-fifths of the global nephrology and urology devices market revenue, and is projected to maintain its lead position during the forecast period. This is attributed to rise in technological advancements and innovations in nephrology and urology devices making it increasingly feasible to perform procedures in hospital settings.
However, the dialysis centers segment is projected to manifest the highest CAGR of 4.8% from 2023 to 2032. This is attributed to the dialysis centers offering specialized care & medical expertise in managing kidney-related conditions, as a result of which, patients prefer these centers for the convenience of receiving treatment from trained professionals in a clinical setting.
According to region, North America held the largest market share in terms of revenue in 2022, accounting for nearly two-fifths of the global nephrology and urology devices market revenue and is likely to dominate the market during the forecast period. This is attributed to the well-established healthcare system, rise in prevalence of urological diseases, technological advancement in devices, and rise in number of product approvals.
However, Asia-Pacific is expected to witness the highest CAGR of 4.9% from 2023 to 2032. Rise in awareness about early diagnosis & treatment, increase in prevalence of urological & kidney diseases, and development of healthcre industry are expected to drive the growth of the nephrology and urology devices market.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/420 ย ย
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
- North America
(U.S., Canada, Mexico) - Europe
(Germany, France, UK, Italy, Spain, Rest of Europe) - Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific) - LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.